Oncology Investigational Drug Service — Baltimore, Maryland

Oncology Investigational Drug Service is a clinical research site located in Baltimore, Maryland, United States 21231-2410.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Oncology Investigational Drug Service has participated in 1 clinical trials.

Therapeutic areas: Acute Lymphoblastic Leukemia.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oncology Investigational Drug Service?

Oncology Investigational Drug Service has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oncology Investigational Drug Service conducted?

Oncology Investigational Drug Service has 1 clinical trials on record. Their work covers Acute Lymphoblastic Leukemia.

Is Oncology Investigational Drug Service accredited by Crixeo Health?

Oncology Investigational Drug Service has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Oncology Investigational Drug Service?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.